Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 1407Neoplasms 1139Prostatic Neoplasms 744Lung Neoplasms 623Colorectal Neoplasms 601Carcinoma, Non-Small-Cell Lung 573Carcinoma, Hepatocellular 414Pancreatic Neoplasms 406Leukemia, Myeloid, Acute 397Stomach Neoplasms 359Multiple Myeloma 325Ovarian Neoplasms 312Brain Neoplasms 311Head and Neck Neoplasms 289Neoplasm Metastasis 273Precursor Cell Lymphoblastic Leukemia-Lymphoma 263Rectal Neoplasms 258Recurrence 250Uterine Cervical Neoplasms 247Melanoma 243Esophageal Neoplasms 241Squamous Cell Carcinoma of Head and Neck 234Glioblastoma 232Lymphoma 213Sarcoma 208Urinary Bladder Neoplasms 195Colonic Neoplasms 194Glioma 192Triple Negative Breast Neoplasms 187Hematologic Neoplasms 185

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × OTHER × Non-Malignant Neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡